Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Naveenchandra Suryadevara(Vanderbilt University Medical Center), Swathi Shrihari(Washington University in St. Louis), Pavlo Gilchuk(Vanderbilt University Medical Center), Laura A. VanBlargan(Washington University in St. Louis), Elad Binshtein(Vanderbilt University Medical Center), Seth J. Zost(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Rachel E. Sutton(Vanderbilt University Medical Center), Emma S. Winkler(Washington University in St. Louis), Elaine C. Chen(Vanderbilt University Medical Center), Mallorie E. Fouch(Integral Molecular (United States)), Edgar Davidson(Integral Molecular (United States)), Benjamin J. Doranz(Integral Molecular (United States)), Rita E. Chen(Washington University in St. Louis), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), Robert H. Carnahan(Vanderbilt University Medical Center), Larissa B. Thackray(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), James E. Crowe(Vanderbilt University Medical Center)
Cell
March 18, 2021
Cited by 407Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis